Insulin Resistance Is Cheerfully Hitched with Hypertension

Area of Science:

• Endocrinology
• Cardiology
• Public Health

Background:

• Cardiovascular diseases (CVD) and type 2 diabetes mellitus (T2DM) show a global increase, especially in developing nations.
• CVD is the primary cause of death and illness in T2DM patients, exacerbated by hypertension.
• Hypertension and T2DM share risk factors like endothelial dysfunction, inflammation, obesity, and dyslipidemia, with hypertension patients exhibiting higher insulin resistance.

Purpose of the Study:

• To explore the intricate relationship between hypertension, insulin resistance, and the escalating prevalence of type 2 diabetes mellitus.
• To elucidate the common pathophysiological mechanisms linking these metabolic and cardiovascular disorders.

Main Methods:

• Review of epidemiological data on the rising incidence of CVD and T2DM.
• Analysis of shared risk factors and pathophysiological pathways connecting hypertension, insulin resistance, and T2DM.
• Examination of molecular and systemic mechanisms implicated in the comorbidity.

Main Results:

• A significant global rise in cardiovascular diseases and type 2 diabetes mellitus observed.
• Strong correlation identified between hypertension, insulin resistance, and increased risk for T2DM and CVD.
• Shared mechanisms including renin-angiotensin-aldosterone system activation, oxidative stress, and inflammation contribute to the association.

Conclusions:

• Hypertension and insulin resistance are critical factors in the development of type 2 diabetes.
• Understanding these interconnected mechanisms is vital for managing and preventing both T2DM and cardiovascular diseases.
• Interventions targeting shared risk factors may mitigate the burden of these prevalent chronic conditions.